Validea’s guru fundamental report for Moderna Inc (MRNA) shows that it rates highest using the Value Investor model based on Benjamin Graham’s strategy. The stock is in the Biotechnology & Drugs industry, with an 86% rating based on underlying fundamentals and valuation. The stock meets most criteria of the strategy, including sales, current ratio, debt ratio, P/E ratio, and price/book ratio. Benjamin Graham, known as the “Father of Value Investing”, mentored legendary investors like Warren Buffett and achieved impressive returns during challenging times. Validea is an investment research service that follows strategies of investment legends.

Read more at Nasdaq: MRNA Quantitative Stock Analysis – Benjamin Graham